Virus Filtration Market Size, Share, Growth Report 2030

Virus Filtration Market

Virus Filtration Market By Product (Virus Filtration Systems, Kits & Reagents, and Services), By Application (Medical Devices, Water Purification, Air Purification, and Biologicals), By End-User (Contract Research Organizations, Medical Devices Companies, Research Institutes, and Pharmaceutical & Biotechnology Companies), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-3367 Published Date: May-2022 Status : Published

The global virus filtration market reached USD 3.59 billion in 2021 and is projected to grow with a compound annual growth rate of approximately 11.9 percent to reach about USD 7.24 billion by 2028.

Industry Prospective:

The global virus filtration market reached USD 3.59 billion in 2021 and is projected to grow with a compound annual growth rate of approximately 11.9 percent to reach about USD 7.24 billion by 2028. The report analyzes the virus filtration market’s drivers, restraints, challenges, and the effect they have on the demands during the projection period. In addition, the report offers significant opportunities that could boost the global virus filtration market over the forecast period.

Virus Filtration Market: Overview

Virus filtration is a simple, effective, and efficient method of maintaining both non-enveloped and enveloped virus particles on the pores or layers of a polymeric membrane. It has a wide range of applications in continuous biological drug manufacturing, and it's becoming more popular for use in monoclonal antibodies as it allows for smaller facility footprints. Because it has no effect on product quality, it is regarded to be an excellent strategy for manufacturing and increasing the safety of biologics such as vaccines, cell lines, and therapeutic recombinant proteins. This approach also removes blood-borne pathogens from plasma-derived products.

COVID-19 Impact:

The global COVID-19 pandemic has fueled demand for viral filtering equipment, as well as kits and reagents, which are in high demand since the start of the COVID-19 vaccine manufacturing. Virus filtration is gaining traction as a critical step in the development of stem cell products, vaccines, and other biological. CRO's and pharmaceutical firms are anticipated to increase their investments in filters and filtration systems, indicating a positive future for the sector. The market for viral filtering technologies is expected to continue to expand in the next years, prompting biotechnology businesses to engage in R&D. Several businesses are expected to invest in technology developments in order to decrease risk, increase flexibility, and save money. The COVID-19 pandemic has accelerated the trend, with manufacturers increasing manufacturing to meet worldwide demand.

Global Virus Filtration MarketRequest Free Sample

Virus Filtration Market: Growth Drivers

Increasing rate of biological drug development is primarily fueling the market growth.

The rise in chronic sickness instances throughout the world has prompted medication developers to create advanced class pharmaceuticals, allowing virus filtering to be used as the foundation technology. It is undeniable that the global disease burden, in respect of chronic illness, has risen. According to the World Health Organization, cancer is responsible for one out of every six deaths globally. Furthermore, diabetes prevalence has tripled in the previous four decades, with an estimated 550 million people worldwide. Chronic diseases can carry with them a slew of other problems, such as renal failure, vision problems, and, finally, heart attacks. The world's major pharmaceutical companies are actively investigating medications and vaccinations that might help to prevent or lessen the severity of the disease. The introduction of new medications necessitates the use of viral filtering techniques in downstream processes, which is therefore allowing the global virus filtration market to expand.

Virus Filtration Market: Restraints

Stringent regulations for the biological process may hamper market growth.

The biological products dealing with the virus are susceptible to environmental hazards, health, and large business losses if not handled correctly. The use of virus filtration techniques is rapidly increasing in biological manufacturing. However, the equipment and process used to filter virus is crucial and need to be monitored and inspected carefully for proper results. This is why the strict laws and regulations for viral filtering product validation are expected to constrain the market to some extent.

Virus Filtration Market: Opportunities

Advent of nanofiber technology expected to offer better growth opportunities for market expansion.

In comparison to the classic electrospinning technique, the new advanced nanofiber coating technology offers higher control, flexibility, and durability in pharmaceutical filtering. Fibers ranging in size from 0.3 to 0.5 microns can be used in this novel coating, which can be raised to 1 micron. The fiber diameter distribution and layer thickness may be readily modified to meet the needs of the application. The NANOWEB advanced nanofiber technology has advantages in both liquid and air filtration, and it can be customized to satisfy the demanding filtering needs of a variety of liquid applications. It also meets the increased need for enhanced microfiltration and ultrafiltration in a wide range of liquid service applications, such as life sciences, process liquid filtration, and food & beverage.

Virus Filtration Market: Challenges

Issues with the continuous filtration process pose a major challenge to market growth.

The virus filter's continuous processing may not operate as expected, resulting in defective batches of items and stifling the global virus filtration market's growth. Virus filtration is an important downstream procedure that may be done in two ways: batch filtration and continuous flow filtration. Because batch systems are closed and more complicated in the continuous viral filtering process, variations in protein content, inconsistent pH values, and conductivity pose a challenge to the virus filter. When the minimum titer was 106 pfu/ml, the filters were also put to the test. Additionally, corporations must pay additional funds to perform parallel filtration, which will allow in-line testing throughout the batch filtration's continuous phase.

Virus Filtration Market: Segmentation

The global virus filtration market is categorized into product, application, end-user, and region. By product, the market is further bifurcated into kits & reagents, virus filtration systems, and services. The applications of virus filtration are categorized into water purification, medical devices, biologicals, and air purification. The end-user segment of the market is divided into research institutes, contract research organizations, medical devices companies, and pharmaceutical & biotechnology firms.

Recent Developments

  • August 2021, Honeywell unveiled its coronavirus "drop-in" filter. The following would be in the form of a coating capable of eradicating 97 percent of the Sars-Cov-19 virus. Furthermore, the product introduction is targeted at schools and government offices that already have heating and cooling systems in place and don't want to spend a lot of money on denser filtration.
  • February 2021, the first virus-killing air purifier has been released by Estonian UV tech. The gadget is worn around the neck and can filter out 99 percent of viruses & germs. The gadget has been demonstrated to be 99.88 percent effective against E. Coli, as well as 99.44 percent effective against Alphavirus. The procedure is then vented to the user after passing via an internal filter and a germicidal UV-C lamp.

Virus Filtration Market: Regional Landscape

North America to dominate the global market during the forecast period.

In comparison to the other regions, North America's viral filtration market maintained a significant market share of 36 percent. It is due to the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Furthermore, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the following region contains several well-known firms. Secondly, the region's focus over the last year has been on developing resilient infrastructure that will prevent further breakouts which might lead to a new pandemic is also supporting the growth of the market. Conversely, Asia Pacific region provides significant development potential for marketers. It is due to an increase in FDI from biotechnology businesses in countries like India and China. The economies of scale offered by the countries, as well as advantageous trade regulations, are boosting the viral filtering market to new heights. Furthermore, due to growing pollution levels in the majority of the countries in this region, air purification has become a popular topic and field of innovation, allowing viral filtering to flourish.

Virus Filtration Market: Competitive Landscape

Key players functioning in the global virus filtration market include General Electric Company, Sartorius AG, Asahi Kasei Medical Co. Ltd., Thermo Fischer Scientific Inc., Danaher Corporation, Clean Cell Inc., Charles River Laboratories International Inc., Wuxi Biologics, and Lonza Group Ltd among others.

Report Scope:

 

Global virus filtration market is segmented as follows:

By Product

  • Virus Filtration Systems
  • Kits & Reagents
  • Services
  • Others

By Application

  • Medical Devices
  • Water Purification
  • Air Purification
  • Biologicals

By End-User

  • Pharmaceuticals & Biotechnology Companies
  • Medical Devices Companies
  • Research Institutes
  • Contract Research Organizations

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

The rise in chronic sickness instances throughout the world has prompted medication developers to create advanced class pharmaceuticals, allowing virus filtering to be used as the foundation technology. It is undeniable that the global disease burden, in respect of chronic illness, has risen. According to the World Health Organization, cancer is responsible for one out of every six deaths globally. Furthermore, diabetes prevalence has tripled in the previous four decades, with an estimated 550 million people worldwide. Chronic diseases can carry with them a slew of other problems, such as renal failure, vision problems, and, finally, heart attacks. The world's major pharmaceutical companies are actively investigating medications and vaccinations that might help to prevent or lessen the severity of the disease.

According to the Zion Market Research report, the global virus filtration market was worth about 3.59 (USD billion) in 2021 and is predicted to grow to around 7.24 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 11.9 percent.

 

In comparison to the other regions, North America's viral filtration market maintained a significant market share of 36 percent. It is due to the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Furthermore, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the following region contains several well-known firms. Secondly, the region's focus over the last year has been on developing resilient infrastructure that will prevent further breakouts which might lead to a new pandemic is also supporting the growth of the market.

Key players functioning in the global virus filtration market include General Electric Company, Sartorius AG, Asahi Kasei Medical Co. Ltd., Thermo Fischer Scientific Inc., Danaher Corporation, Clean Cell Inc., Charles River Laboratories International Inc., Wuxi Biologics, and Lonza Group Ltd among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed